查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1765260

全球結構性心臟疾病器材市場

Structural Heart Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球結構性心臟疾病設備市場規模將達 280 億美元

全球結構性心臟疾病器械市場規模預計在2024年為152億美元，預計到2030年將達到280億美元，2024年至2030年的複合年成長率為10.7%。心臟瓣膜器械是本報告分析的細分市場之一，預計其複合年成長率為11.3%，到分析期結束時規模將達到119億美元。外科心臟瓣膜細分市場在分析期間的複合年成長率預計為10.7%。

美國市場規模估計為 42 億美元，中國市場預期複合年成長率為 10.0%

美國結構性心臟疾病器械市場規模預計2024年達到42億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到43億美元，在2024-2030年的分析期間內，複合年成長率為10.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為9.5%和9.1%。在歐洲，預計德國市場的複合年成長率約為8.3%。

全球結構性心臟疾病設備市場—主要趨勢與促進因素摘要

結構性心臟疾病裝置在現代醫學中扮演什麼角色？

結構性心臟疾病裝置對於治療主動脈瓣狹窄、二尖瓣瓣膜閉鎖不全和心房中膈缺損症等結構性心臟疾病患者至關重要。這些裝置包括心臟瓣膜、封堵器、環狀成形術環和閉塞器，有助於修復或更換心臟受損或變形的部分。經導管主動脈瓣置換術(TAVR) 等微創技術的使用正在徹底改變心血管護理，它減少了開胸手術的需求，從而縮短了康復時間並縮短了住院時間。隨著全球人口老化和心血管疾病的盛行率上升，結構性心臟疾病裝置在滿足手術併發症高風險患者的需求方面變得越來越重要。

哪些技術創新推動了結構性心臟疾病設備的發展？

技術創新是結構性心臟疾病器械市場的前沿，創新重點在於提高器械功效、降低手術風險和改善患者預後。其中最重要的發展之一是經導管技術，該技術無需開放性手術即可修復或更換心臟瓣膜。此外，3D超音波心動圖和MRI等影像技術的改進使得手術計劃和執行更加精確，從而減少併發症。此外，生物相容性材料的進步正在提高心臟瓣膜的耐用性和性能，而智慧技術的整合則實現了即時監測和術後護理。

哪個細分市場正在引領結構性心臟疾病設備的採用？

器械類型包括心臟瓣膜、封堵器、環狀成形術環等。心臟瓣膜，尤其是經導管心臟瓣膜，因其廣泛用於治療心臟瓣膜疾病而佔據市場主導地位。經導管主動脈瓣置換術(TAVR) 和經導管二尖瓣瓣膜修復(TMVR) 等手術正在推動對微創器械的需求。最終用戶包括醫院、門診手術中心和專科診所，其中醫院因其擁有先進的醫療技術而成為最大的採用者。雖然北美和歐洲是結構性心臟疾病器材的最大市場，但亞太地區正因醫療基礎設施的改善和人們對心血管治療意識的提高而迅速崛起。

是什麼推動了結構性心臟疾病設備市場的成長？

結構性心臟疾病器械市場的成長受到多種因素的推動，例如心血管疾病盛行率的上升、微創手術的普及以及經導管技術的進步。全球人口老化，尤其是在已開發地區，正在推動對心臟瓣膜置換術和其他結構性心臟介入治療的需求。影像處理和生物相容性材料的技術創新正在提高這些器材的安全性和有效性，從而提高其採用率。此外，醫療保健支出的增加以及政府為改善先進心臟護理的可及性而採取的舉措，也推動了市場的成長，尤其是在新興市場。

部分

產品（心臟瓣膜裝置、外科心臟瓣膜、經​​導管心臟瓣膜、封堵器及輸送系統、其他產品）

受訪公司範例

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Micro Interventional Devices, Inc.
  • TTK Healthcare Ltd.

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP15047

Global Structural Heart Devices Market to Reach US$28.0 Billion by 2030

The global market for Structural Heart Devices estimated at US$15.2 Billion in the year 2024, is expected to reach US$28.0 Billion by 2030, growing at a CAGR of 10.7% over the analysis period 2024-2030. Heart Valve Devices, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$11.9 Billion by the end of the analysis period. Growth in the Surgical Heart Valves segment is estimated at 10.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 10.0% CAGR

The Structural Heart Devices market in the U.S. is estimated at US$4.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.5% and 9.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Structural Heart Devices Market - Key Trends and Drivers Summarized

What Role Do Structural Heart Devices Play in Modern Medicine?

Structural heart devices are critical in treating patients with structural heart diseases, including conditions such as aortic stenosis, mitral regurgitation, and atrial septal defects. These devices include heart valves, occluders, annuloplasty rings, and closure devices, which help repair or replace damaged or malformed parts of the heart. The use of minimally invasive technologies, such as transcatheter aortic valve replacement (TAVR), has revolutionized cardiovascular care by reducing the need for open-heart surgery, leading to faster recovery times and reduced hospital stays. As the global population ages and the prevalence of cardiovascular diseases rises, structural heart devices are becoming increasingly essential in addressing the needs of patients who are at higher risk of surgical complications.

What Technological Innovations Are Driving Growth in Structural Heart Devices?

Technological advancements are at the forefront of the structural heart devices market, with innovations focusing on improving device efficacy, reducing procedural risks, and enhancing patient outcomes. One of the most significant developments is in transcatheter technologies, which allow for the repair or replacement of heart valves without open surgery. Improvements in imaging technologies, such as 3D echocardiography and MRI, are also enabling more precise planning and execution of procedures, reducing complications. Additionally, advancements in biocompatible materials are enhancing the durability and performance of heart valves, while the integration of smart technologies is enabling real-time monitoring and post-procedure care.

Which Market Segments Are Leading the Adoption of Structural Heart Devices?

Device types include heart valves, closure devices, occluders, and annuloplasty rings, with heart valves, particularly transcatheter heart valves, dominating the market due to their widespread use in treating valvular heart diseases. Procedures such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR) are driving demand for minimally invasive devices. End-users include hospitals, ambulatory surgical centers, and specialty clinics, with hospitals being the largest adopters due to their access to advanced medical technologies. North America and Europe are the largest markets for structural heart devices, while Asia-Pacific is rapidly emerging due to improving healthcare infrastructure and increasing awareness of cardiovascular care.

What Is Driving the Growth of the Structural Heart Devices Market?

The growth in the structural heart devices market is driven by several factors, including the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and advancements in transcatheter technologies. The aging global population, particularly in developed regions, is driving the demand for heart valve replacements and other structural heart interventions. Technological innovations in imaging and biocompatible materials are enhancing the safety and efficacy of these devices, leading to higher adoption rates. Additionally, increasing healthcare expenditure and government initiatives to improve access to advanced cardiac care are fueling market growth, particularly in emerging markets.

SCOPE OF STUDY:

The report analyzes the Structural Heart Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems, Other Products)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Micro Interventional Devices, Inc.
  • TTK Healthcare Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Structural Heart Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Cardiovascular Diseases Drives Demand for Structural Heart Devices
    • Technological Advancements in Minimally Invasive Heart Valve Repair Propels Market Growth
    • Rising Adoption of Transcatheter Aortic Valve Replacement (TAVR) Expands Addressable Market Opportunity
    • Increasing Geriatric Population Strengthens Business Case for Structural Heart Devices
    • Surge in Heart Valve Replacement Procedures Accelerates Demand for Advanced Structural Heart Devices
    • Regulatory Approvals for Next-Generation Structural Heart Devices Propel Innovation in the Market
    • Growing Use of Structural Heart Devices in Treating Congenital Heart Defects Creates New Opportunities
    • Focus on Improving Patient Outcomes and Reducing Procedure Times Drives Adoption of Structural Heart Devices
    • Regulatory Changes and Increasing Healthcare Expenditure in Emerging Markets Fuel Market Growth
    • Surge in Demand for Non-Surgical and Minimally Invasive Treatment Options Spurs Adoption
    • Growing Awareness of Structural Heart Diseases and Diagnostic Tools Strengthens Market Penetration
    • Increasing Use of Structural Heart Devices in Hybrid Operating Rooms Expands Global Market Reach
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Structural Heart Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Structural Heart Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Structural Heart Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Heart Valve Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Heart Valve Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Surgical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Surgical Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Occluders & Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Occluders & Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 17: Canada 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • JAPAN
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 18: Japan Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: Japan 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • CHINA
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • EUROPE
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 22: Europe Recent Past, Current & Future Analysis for Structural Heart Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: Europe 6-Year Perspective for Structural Heart Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 24: Europe Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Europe 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • FRANCE
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 26: France Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: France 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • GERMANY
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 28: Germany Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Germany 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • ITALY
    • TABLE 30: Italy Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Italy 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • UNITED KINGDOM
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 32: UK Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: UK 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 34: Rest of Europe Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Rest of Europe 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 36: Asia-Pacific Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Asia-Pacific 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 38: Rest of World Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Rest of World 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030

IV. COMPETITION